Revolution Medicine CEO says insurers should act swiftly on $39,800 drug
Revolution Medicine’s CEO Goldsmith expects insurers to provide coverage swiftly for its $39,800 monthly cancer drug.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.